<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010077283">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="bold" font="default" size="100%">Ayouba, Ahidjo</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Butel, Christelle</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Cournil, Amandine</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Delaporte, E.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Eymard-Duvernay, Sabrina</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Granouillac, Bruno</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Izard, Suzanne</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Lacroix, Audrey</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Leroy, S.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Peeters, Martine</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">et al.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">NAMSAL ANRS 12313 Study Group</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Dolutegravir-based or low-dose Efavirenz-based regimen for the treatment of HIV-1</title>
        <secondary-title>New England Journal of Medicine</secondary-title>
      </titles>
      <pages>816-826</pages>
      <keywords>
        <keyword>CAMEROUN</keyword>
      </keywords>
      <dates>
        <year>2019</year>
      </dates>
      <call-num>fdi:010077283</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>New England Journal of Medicine</full-title>
      </periodical>
      <isbn>0028-4793</isbn>
      <accession-num>ISI:000484431200009</accession-num>
      <number>9</number>
      <electronic-resource-num>10.1056/NEJMoa1904340</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010077283</url>
        </related-urls>
        <pdf-urls>
          <url>https://www.documentation.ird.fr/intranet/publi/depot/2020-02-26/010077283.pdf</url>
        </pdf-urls>
      </urls>
      <volume>381</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <custom6>052MALTRA03</custom6>
    </record>
  </records>
</xml>
